Seborrheic Dermatitis

  • Clinton Enos
  • Tulsie Patel
  • Shailee Patel
  • Katlein FrançaEmail author


Seborrheic dermatitis (SD) is a chronic relapsing inflammatory process in the skin. SD has multiple clinical variants impacting both pediatric and adult populations as well as special populations such as those that are immunocompromised or suffer from neurologic disorders. SD often affects areas of the skin with greater sebaceous gland density and may cause a greasy appearance. Stress, anxiety, and emotion have all been suggested as both a trigger for and exacerbating factor of SD flares, however further investigation is required. Studies measuring quality of life indicate that SD may predispose patients to depression. Further, patients with SD often report embarrassment as a major complaint. The link between stress and SD should be carefully considered when caring for patients with SD. Management of both the psychological wellbeing and skin will have a potential synergistic effect on prognosis of patients.


Seborrheic dermatitis Embarrassment Stress Anxiety 


  1. 1.
    Gary G. Optimizing treatment approaches in seborrheic dermatitis. J Clin Aesthet Dermatol. 2013;6:44–9.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Naldi L, Rebora A. Clinical practice. Seborrheic dermatitis. N Engl J Med. 2009;360:387–96.CrossRefPubMedGoogle Scholar
  3. 3.
    Berk T, Scheinfeld N. Seborrheic dermatitis. Pharm Ther. 2010;35:348–52.Google Scholar
  4. 4.
    Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol JEADV. 2004;18:13–26; quiz 19–20.CrossRefPubMedGoogle Scholar
  5. 5.
    Schwartz RA, Janusz CA, Janniger CK. Seborrheic dermatitis: an overview. Am Fam Physician. 2006;74:125–30.PubMedGoogle Scholar
  6. 6.
    Johnson MT, Roberts J. Skin conditions and related need for medical care among persons 1-74 years. United States, 1971–1974. Vital Health Stat 11. 1978:i–v, 1–72.Google Scholar
  7. 7.
    Peyrí J, Lleonart M, Grupo español del Estudio SEBDERM. Clinical and therapeutic profile and quality of life of patients with seborrheic dermatitis. Actas Dermosifiliogr. 2007;98:476–82.CrossRefPubMedGoogle Scholar
  8. 8.
    Janniger CK. Infantile seborrheic dermatitis: an approach to cradle cap. Cutis. 1993;51:233–5.PubMedGoogle Scholar
  9. 9.
    Ooi ET, Tidman MJ. Improving the management of seborrhoeic dermatitis. Practitioner. 2014;258:23–6, 3.PubMedGoogle Scholar
  10. 10.
    Sonea MJ, Moroz BE, Reece ER. Leiner’s disease associated with diminished third component of complement. Pediatr Dermatol. 1987;4:105–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Sarifakioglu E, Yilmaz AE, Gorpelioglu C, Orun E. Prevalence of scalp disorders and hair loss in children. Cutis. 2012;90:225–9.PubMedGoogle Scholar
  12. 12.
    Williamson D, Gonzalez M, Finlay AY. The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol JEADV. 2001;15:137–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Wolf R, Orion E, Tüzün Y. Periorbital (eyelid) dermatides. Clin Dermatol. 2014;32:131–40.CrossRefPubMedGoogle Scholar
  14. 14.
    Araya M, Kulthanan K, Jiamton S. Clinical characteristics and quality of life of seborrheic dermatitis patients in a tropical country. Indian J Dermatol. 2015;60:519.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Mathes BM, Douglass MC. Seborrheic dermatitis in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol. 1985;13:947–51.CrossRefPubMedGoogle Scholar
  16. 16.
    Motswaledi MH, Visser W. The spectrum of HIV-associated infective and inflammatory dermatoses in pigmented skin. Dermatol Clin. 2014;32:211–25.CrossRefPubMedGoogle Scholar
  17. 17.
    Soeprono FF, Schinella RA, Cockerell CJ, Comite SL. Seborrheic-like dermatitis of acquired immunodeficiency syndrome. A clinicopathologic study. J Am Acad Dermatol. 1986;14:242–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Senaldi G, Di Perri G, Di Silverio A, Minoli L. Seborrhoeic dermatitis: an early manifestation in AIDS. Clin Exp Dermatol. 1987;12:72–3.CrossRefPubMedGoogle Scholar
  19. 19.
    Vidal C et al. Seborrheic dermatitis and HIV infection. Qualitative analysis of skin surface lipids in men seropositive and seronegative for HIV. J Am Acad Dermatol. 1990;23:1106–10.CrossRefPubMedGoogle Scholar
  20. 20.
    Alessi E, Cusini M, Zerboni R. Mucocutaneous manifestations in patients infected with human immunodeficiency virus. J Am Acad Dermatol. 1988;19:290–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Blanes M et al. Current prevalence and characteristics of dermatoses associated with human immunodeficiency virus infection. Actas Dermosifiliogr. 2010;101:702–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Arsic Arsenijevic VS et al. A laboratory-based study on patients with Parkinson’s disease and seborrheic dermatitis: the presence and density of Malassezia yeasts, their different species and enzymes production. BMC Dermatol. 2014;14:5.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Shuster S et al. Melanocyte-stimulating hormone and parkinsonism. Lancet Lond Engl. 1973;1:463–4.CrossRefGoogle Scholar
  24. 24.
    Cowley NC, Farr PM, Shuster S. The permissive effect of sebum in seborrhoeic dermatitis: an explanation of the rash in neurological disorders. Br J Dermatol. 1990;122:71–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Bettley FR, Marten RH. Unilateral seborrheic dermatitis following a nerve lesion. AMA Arch Dermatol. 1956;73:110–5.CrossRefGoogle Scholar
  26. 26.
    Chen TM, Fitzpatrick JE. Unilateral seborrheic dermatitis after decompression of Chiari I malformation and syringomyelia. J Am Acad Dermatol. 2006;55:356–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Rocha N, Velho G, Horta M, Martins A, Massa A. Cutaneous manifestations of familial amyloidotic polyneuropathy. J Eur Acad Dermatol Venereol JEADV. 2005;19:605–7.CrossRefPubMedGoogle Scholar
  28. 28.
    Ercis M, Balci S, Atakan N. Dermatological manifestations of 71 Down syndrome children admitted to a clinical genetics unit. Clin Genet. 1996;50:317–20.PubMedGoogle Scholar
  29. 29.
    Okada K et al. Refractory seborrheic dermatitis of the head in a patient with malignant lymphoma. Case Rep Dermatol. 2014;6:279–82.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Kokturk A et al. Seborrhoeic dermatitis-like manifestation of lung cancer evolving into erythrodermia. J Eur Acad Dermatol Venereol JEADV. 2004;18:381–2.CrossRefPubMedGoogle Scholar
  31. 31.
    Venkateswaran S, Garg BR, Reddy BS, Narasimhan R. Cutaneous lymphoma mimicking seborrhoeic dermatitis. Indian J Dermatol Venereol Leprol. 1995;61:45–7.PubMedGoogle Scholar
  32. 32.
    Bittencourt AL, de Oliveira Mde FP. Cutaneous manifestations associated with HTLV-1 infection. Int J Dermatol. 2010;49:1099–110.CrossRefPubMedGoogle Scholar
  33. 33.
    Tegner E. Seborrhoeic dermatitis of the face induced by PUVA treatment. Acta Derm Venereol. 1983;63:335–9.PubMedGoogle Scholar
  34. 34.
    Weiss SC, Rowell R, Krochmal L. Impact of seasonality on conducting clinical studies in dermatology. Clin Dermatol. 2008;26:565–9.CrossRefPubMedGoogle Scholar
  35. 35.
    Picardi A, Abeni D. Stressful life events and skin diseases: disentangling evidence from myth. Psychother Psychosom. 2001;70:118–36.CrossRefPubMedGoogle Scholar
  36. 36.
    Oztas P, Calikoglu E, Cetin I. Psychiatric tests in seborrhoeic dermatitis. Acta Derm Venereol. 2005;85:68–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Misery L et al. Stress and seborrheic dermatitis. Ann Dermatol Vénéréologie. 2007;134:833–7.CrossRefGoogle Scholar
  38. 38.
    Maietta G, Fornaro P, Rongioletti F, Rebora A. Patients with mood depression have a high prevalence of seborrhoeic dermatitis. Acta Derm Venereol. 1990;70:432–4.PubMedGoogle Scholar
  39. 39.
    Orion E, Wolf R. Psychologic factors in the development of facial dermatoses. Clin Dermatol. 2014;32:763–6.CrossRefPubMedGoogle Scholar
  40. 40.
    Humphreys F, Humphreys MS. Psychiatric morbidity and skin disease: what dermatologists think they see. Br J Dermatol. 1998;139:679–81.CrossRefPubMedGoogle Scholar
  41. 41.
    Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Clinton Enos
    • 1
  • Tulsie Patel
    • 2
  • Shailee Patel
    • 2
  • Katlein França
    • 3
    • 4
    Email author
  1. 1.Eastern Virginia Medical SchoolNorfolkUSA
  2. 2.Department of Dermatology and Cutaneous SurgeryUniversity of Miami Miller School of MedicineMiamiUSA
  3. 3.Centro Studi per la Ricerca Multidisciplinare e RigenerativaUniversità Degli Studi “G. Marconi”RomeItaly
  4. 4.Department of Dermatology and Cutaneous Surgery, Department of Psychiatry and Behavioral SciencesInstitute for Bioethics and Health Policy, University of Miami Miller School of MedicineMiamiUSA

Personalised recommendations